How GLP-1 Medications Affect Blood Pressure in Patients with Hypertension Weight loss often leads to a decreased need for blood pressure medications, which can pose risks for patients who are currently on anti-hypertensive medications (blood pressure pills)
Kenneth Custer, head of cardiometabolic health at Lilly, said that with Zepbound, Foundayo and retatrutide, the company can "match treatments to the needs and preferences of patientsacross various stages of their obesity journey." The company is thought to be waiting for the results of two more trials later this year TRIUMPH-2 in obesity or overweight and type 2 diabetes, and TRIUMPH-3 in obesity or overweight and established cardiovascular disease before filing retatrutide for approval in late 2027 or early 2028.
Mounjaro does not cause withdrawal side effects in the way addictive medicines do
In the gout state, abnormal activation of FXR and pro-inflammatory cytokines can suppress BA production, leading to the dysregulation of BA metabolism
We will update this article as new data emerges
Unlike the fat beneath your skin, visceral fat is more active, releasing hormones and chemicals that can lead to inflammation and insulin resistance